Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Report

China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Market Research Report 2023-2029

  • POSTDATE：Sep 13, 2023
  • PAGES：210
  • REPORT CODE：GMM1795329
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Janssen Pharmaceuticals

    • Boehringer Ingelheim

    • Astellas

    • Eli Lilly

    • Kotobuki Pharmaceutical

    • AstraZeneca

    By Type:

    • Suglat (Ipragliflozin)

    • Farxiga/Forxiga (Dapagliflozin)

    • Jardiance (Empagliflozin)

    • Invokana (Canagliflozin)

    By Application:

    • Medical Research Institute

    • Other

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Overview 2018-2029

    • 1.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Development Overview

    • 1.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Development History

    • 1.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Market Size (2018-2029)

    • 1.4 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis by Type from Production Side

      • 1.4.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume, Production Value and Growth Rate of Suglat (Ipragliflozin) (2018-2029)

      • 1.4.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume, Production Value and Growth Rate of Farxiga/Forxiga (Dapagliflozin) (2018-2029)

      • 1.4.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume, Production Value and Growth Rate of Jardiance (Empagliflozin) (2018-2029)

      • 1.4.4 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume, Production Value and Growth Rate of Invokana (Canagliflozin) (2018-2029)

    • 1.5 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis by Application from Consumption End

      • 1.5.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate of Medical Research Institute (2018-2029)

      • 1.5.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis by Region

      • 1.6.1 North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

    Chapter 2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status and Competition Analysis in 2023

      • 2.2.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Development

    Chapter 3 Sodium/Glucose Cotransporter 2 (SGLT 2) InhibitorsIndustry Chain Analysis

    • 3.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Chain

    • 3.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market

    • 3.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market

    Chapter 4 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 4.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Total Production Volume and Growth Rate from Production Side

    • 4.5 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume and Growth Rate, by Type

      • 4.5.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume and Growth Rate of Suglat (Ipragliflozin)

      • 4.5.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume and Growth Rate of Farxiga/Forxiga (Dapagliflozin)

      • 4.5.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume and Growth Rate of Jardiance (Empagliflozin)

      • 4.5.4 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume and Growth Rate of Invokana (Canagliflozin)

    Chapter 5 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Total Market Size and Growth Rate from Consumption End

    • 5.5 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate, by Application

      • 5.5.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Medical Research Institute

      • 5.5.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Other

      • 5.5.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Hospital

    Chapter 6 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Region

    • 6.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume and Production Value, by Region

    • 6.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Sales Value, by Region

    Chapter 7 North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 7.1 North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 7.2 North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    Chapter 8 Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 8.1 Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 8.2 Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    Chapter 9 South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 9.1 South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 9.2 South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    Chapter 10 East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 10.1 East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 10.2 East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    Chapter 11 Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 11.1 Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 11.2 Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    Chapter 12 Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 12.1 Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 12.2 Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    Chapter 13 Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 13.1 Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 13.2 Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Janssen Pharmaceuticals

        • 14.1.1 Janssen Pharmaceuticals Company Profile

        • 14.1.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Boehringer Ingelheim

        • 14.2.1 Boehringer Ingelheim Company Profile

        • 14.2.2 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Astellas

        • 14.3.1 Astellas Company Profile

        • 14.3.2 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Eli Lilly

        • 14.4.1 Eli Lilly Company Profile

        • 14.4.2 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Kotobuki Pharmaceutical

        • 14.5.1 Kotobuki Pharmaceutical Company Profile

        • 14.5.2 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 AstraZeneca

        • 14.6.1 AstraZeneca Company Profile

        • 14.6.2 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Performance

        • 14.6.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Research Conclusions

    • 15.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Market Size (2018-2029)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume, Production Value and Growth Rate of Suglat (Ipragliflozin) (2018-2029)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume, Production Value and Growth Rate of Farxiga/Forxiga (Dapagliflozin) (2018-2029)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume, Production Value and Growth Rate of Jardiance (Empagliflozin) (2018-2029)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume, Production Value and Growth Rate of Invokana (Canagliflozin) (2018-2029)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate of Medical Research Institute (2018-2029)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2018

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2023

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume and Growth Rate of Suglat (Ipragliflozin) (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume and Growth Rate of Farxiga/Forxiga (Dapagliflozin) (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume and Growth Rate of Jardiance (Empagliflozin) (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume and Growth Rate of Invokana (Canagliflozin) (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2018

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2023

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Total Market Size and Growth Rate from Consumption End

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Medical Research Institute (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Other (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume by Region (2018-2023)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Region (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Region (2018-2023)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Value by Region (2018-2023)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Value Share by Region (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Value Share by Region (2018-2023)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Region (2018-2023)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Region (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Region (2018-2023)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value by Region (2018-2023)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Share by Region (2018-2023)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Share by Region (2018-2023)

    • Table North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume by Type (2018-2023)

    • Table North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Table North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Application (2018-2023)

    • Table North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure North China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume by Type (2018-2023)

    • Table Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Table Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Application (2018-2023)

    • Table Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Central China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume by Type (2018-2023)

    • Table South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Table South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Application (2018-2023)

    • Table South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure South China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume by Type (2018-2023)

    • Table East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Table East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Application (2018-2023)

    • Table East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure East China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume by Type (2018-2023)

    • Table Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Table Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Application (2018-2023)

    • Table Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume by Type (2018-2023)

    • Table Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Table Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Application (2018-2023)

    • Table Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume by Type (2018-2023)

    • Table Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Volume Share by Type (2018-2023)

    • Table Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Application (2018-2023)

    • Table Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Janssen Pharmaceuticals Company Profile

    • Table Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Astellas Company Profile

    • Table Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Kotobuki Pharmaceutical Company Profile

    • Table Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US